This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
by Zacks Equity Research
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva Expands Market Reach Through Targeted Strategic Partnerships
by Harshit Gupta
VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
by Harshit Gupta
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
Veeva Systems (VEEV) reached $281 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
by Indrajit Bandyopadhyay
OPRX raised guidance after record Q1 EBITDA, but pharma budget shifts and margin mix pose new challenges ahead.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation
by Harshit Gupta
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
Here's Why Veeva Systems (VEEV) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Veeva (VEEV) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is It Worth Investing in Veeva (VEEV) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines
by Zacks Equity Research
WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
What Makes Veeva (VEEV) a New Strong Buy Stock
by Zacks Equity Research
Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Salesforce vs. Veeva: Which Cloud CRM Stock Is the Smarter Buy?
by Anirudha Bhagat
VEEV's niche focus and strong margins give it an edge over CRM despite its higher valuation and smaller scale.
Best Momentum Stock to Buy for June 25th
by Zacks Equity Research
AEM, VEEV and EVR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 25, 2025.
Veeva Systems (VEEV) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
How to Find Strong Buy Medical Stocks Using the Zacks Rank
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
New Strong Buy Stocks for June 25th
by Zacks Equity Research
BILI, AEM, EVR, VEEV and BCRX have been added to the Zacks Rank #1 (Strong Buy) List on June 25, 2025.
If You Invested $1000 in Veeva Systems a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Top Research Reports for Meta Platforms, Palantir & Abbott
by Mark Vickery
META, PLTR, and ABT lead today's top research picks, with strong AI momentum, product innovation, and expanding market share.
Zacks Market Edge Highlights: Veeva Systems, Howmet Aerospace and Flotek Industries
by Zacks Equity Research
VEEV, HWM, and FTK make the Zacks Market Edge short list as rising earnings and bullish momentum drive investor interest.
How to Use the Zacks Rank to Find Top Stocks
by Tracey Ryniec
Tracey Ryniec, Zacks Senior Stock Strategist, shares her Zacks Rank secrets and highlights 3 stocks.
VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma
by Zacks Equity Research
Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.
Veeva Systems and PulteGroup have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Veeva Systems surges on AI-driven earnings growth, while PulteGroup slips amid fading forecasts and housing headwinds.